Clinical Study

Evaluation of a Smoking Cessation Program for HIV Infected Individuals in an Urban HIV Clinic: Challenges and Lessons Learned

Table 3

Multivariate analysis of predictors associated with tobacco abstinence1.

VariableOR (95% CI)-valueORAdj (95% CI)Adjusted value

Age < 50, years0.86 (0.32–2.28)0.76NS
Male sex0.87 (0.34–2.28)0.78NS
Black race0.97 (0.25–3.70)0.96NS
History of mental illness0.44 (0.02–1.18)0.10NS
Cocaine or heroin use, past or current0.23 (0.08–0.61)0.000.20 (0.07–0.56)0.002
Moderate/high nicotine dependence (FTND ≥5)20.41 (0.15–1.09)0.07NS
Preparation Stage of Change37.19 (0.92–56.24)0.068.26 (1.02–66.67)0.048

OR = odds ratio; CI = confidence interval; ORAdj = adjusted odds ratio; NS = not significant.
1Final model included age, sex, race, history of mental illness, history of heroin or cocaine use, nicotine dependence, and stage of change; due to 1 missing value.
2As measured by the modified Fagerstrom Test for Nicotine Dependence (FTND); score of ≥5 indicates significant nicotine dependence; score of ≤4 indicates low-moderate nicotine dependence.
3As measured by stage of change short form: precontemplation and contemplation versus preparation stage of change, excluding 1 missing value.